|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
There are no as such competitors for HCW Biologics.
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on November 19, 2021. The analyst firm set a price target for 10.00 expecting HCWB to rise to within 12 months (a possible 280.23% upside). 1 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $2.63 last updated Fri Dec 03 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for HCW Biologics.
HCW Biologics’s $Q4 earnings are confirmed for after-market on February 15, 2022.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the sector and industry. They are listed on the NASDAQ.